Notice of AGM and posting of Report & Accounts

ImmuPharma PLC (LSE:IMM), (“ImmuPharma” or the “Company”), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2018, and the Notice of Annual General Meeting has been posted to shareholders.

These documents are available, in electronic form, for download on the Company’s website www.immupharma.co.uk

ImmuPharma’s Annual General Meeting will be held on Thursday 27 June at 10:30am (BST) at the offices of: Capital Access Group, 107 Cheapside, London, EC2V 6DN.